FormFactor, Inc. filings document a Nasdaq-listed semiconductor test and measurement company with common stock registered under the symbol FORM. Its Form 8-K reports furnish quarterly operating results and financial-condition updates, while other material-event filings cover restructuring actions tied to manufacturing consolidation, executive and director changes, and a revolving credit agreement for working capital and general corporate purposes.
The company’s proxy materials describe board elections, committee matters, executive compensation, equity awards, pay-versus-performance disclosure and other annual meeting governance subjects. Together, the filings provide formal disclosure on FormFactor’s capital structure, governance practices, operating performance and risk-related corporate actions.
FormFactor, Inc. reported third-quarter revenue of $280.5 million, up 38.4% from a year earlier, and net income of $73.8 million versus $15.7 million. Gross margin was 54.7%, compared with 39.8%. For the first nine months, revenue was $764.9 million and net income was $150.4 million; operating cash flow was $211.0 million, versus $69.4 million a year earlier.
It received approximately $9.9 million in IEEPA tariff refunds by September 26, 2026, and expects another $1.8 million in the fourth quarter; those refunds added approximately $8.6 million to third-quarter gross profit and are not expected to provide a similar future benefit. Nine-month restructuring charges were $30.7 million, against an estimated total range of $32.0 million to $40.0 million. On October 6, 2026, FormFactor agreed to issue and sell 2,234,887 common shares to Teradyne for approximately $300.0 million in aggregate cash consideration; closing is expected in fourth-quarter fiscal 2026, subject to customary closing conditions.
FormFactor, Inc. (FORM) reported third-quarter fiscal 2026 revenue of $280.5 million for the quarter ended September 26, 2026, up 38.4% from a year earlier and 8.6% from the prior quarter, marking its fourth consecutive quarterly revenue record. GAAP net income was $73.8 million, or $0.93 per diluted share, versus $15.7 million and $0.20 per diluted share a year earlier. GAAP gross margin was 54.7%, versus 39.8% a year earlier; GAAP net cash provided by operating activities was $104.3 million and free cash flow was $64.8 million.
For the fourth quarter ending December 26, 2026, FormFactor forecast revenue of $285 million, plus or minus $10 million; GAAP gross margin of 52.3%, plus or minus 1.5%; and GAAP diluted EPS of $0.84, plus or minus $0.09. Non-GAAP outlook included gross margin of 54.0%, plus or minus 1.5%, and diluted EPS of $0.95, plus or minus $0.09. The outlook assumes consistent foreign currency rates. Management said productivity gains at its existing manufacturing footprint are moderating as it approaches capacity limits and that the Farmers Branch factory is being brought online. After quarter-end, FormFactor announced an expansion of its longstanding partnership with Teradyne aimed at next-generation semiconductor applications.
FormFactor Inc. reported an exempt equity offering under Rule 506(b), with a total amount sold of $300,000,056 USD and $0 USD remaining to be sold. The first sale occurred on October 6, 2026.
The company stated that gross proceeds will be used for general corporate purposes and working capital, with no proceeds used for payments to executive officers, directors or promoters. It reported $0 USD in finders' fees and stated that no sales commissions or finders' fees were incurred or paid.
FormFactor Inc. CEO and director Mike Slessor sold 11,098 shares of common stock in three direct transactions on October 14, 2026: 2,195 shares at a weighted average sale price of $124.23 per share, 7,703 at $125.36, and 1,200 at $125.92. The sales occurred automatically under a Rule 10b5-1 trading plan adopted August 19, 2025.
FormFactor, Inc. (FORM) lists a proposed sale by Mike Slessor of 11,098 common shares, with an aggregate market value of $1,389,437.42 and an approximate sale date of October 14, 2026. The shares are identified as Performance Shares acquired from the issuer on August 1, 2025. Slessor also reported earlier sales of 17,510 shares on September 16, 2026; 16,002 shares on August 14, 2026; and 4,735 shares on July 15, 2026.
FormFactor agreed to issue and sell Teradyne 2,234,887 shares of its common stock in a private placement for approximately $300.0 million in aggregate cash consideration. The transaction is expected to close in the fourth quarter of fiscal 2026, subject to customary closing conditions and regulatory approvals.
The companies also announced a broad technology collaboration covering high-performance compute, advanced packaging, high-bandwidth memory and silicon photonics. They said they will partner to advance semiconductor test architectures, optimize test infrastructure and enhance production readiness.
FORMFACTOR INC (FORM) reported that CEO and director Mike Slessor sold a total of 17,510 shares of common stock on September 16, 2026 in open-market or private transactions. The sales were made under a Rule 10b5-1 trading plan adopted on August 19, 2025.
The transactions included 8,737 shares at a weighted average price of $104.26 (range $103.65–$104.63), 7,773 shares at a weighted average price of $105.12 (range $104.66–$105.615), and 1,000 shares at $105.80.
FORMFACTOR, INC. (FORM) has a notice under Rule 144 indicating that Mike (Michael) David Slessor plans to sell common stock through Morgan Stanley Smith Barney LLC. The filing covers up to 6,412 shares of restricted stock and 11,098 performance share units, all dated August 1, 2025.
The notice also lists prior sales by Mike Slessor over the last three months, including 16,002 common shares on August 14, 2026 and 4,735 common shares on July 15, 2026, with corresponding aggregate values reported for each sale.
FORMFACTOR INC (FORM) director Kelley Steven-Waiss reported selling 2,100 shares of common stock on September 3, 2026 at an average price of $96.10 per share in an open-market or private transaction. After this sale, the director directly holds 24,426 shares of FORM common stock. No Rule 10b5-1 trading plan is reported.
FORMFACTOR, INC. (FORM) received a Rule 144 notice that director Kelley Lynne Steven-Waiss plans to sell restricted common stock. The filing covers a proposed sale of 2,100 shares of common stock, acquired from the issuer on May 16, 2026, to be sold through Morgan Stanley Smith Barney LLC.
The shares are listed on NASDAQ, and the proposed transaction date is September 3, 2026. The filing states an aggregate market value for the covered securities of $201,810.21, providing investors with visibility into a potential insider sale, though the company itself is not a party to the transaction.